Noxopharm has appointed Dr Olivier Laczka as its new Chief Executive Officer with immediate effect, marking a leadership transition as the clinical-stage company positions itself to capitalise on emerging opportunities in its pipeline.
Noxopharm appoints Dr Olivier Laczka as CEO to lead next phase of growth
April 15, 2026 Australian Biotech
Latest Video
New Stories
-
Has any patient ever said they accept a rejection because of the Kaplan-Meier curve?
August 17, 2026 - - Latest News -
Pharmac aims to pivot toward faster process and broader value framework
August 17, 2026 - -
The 'Dispatched' Podcast - Series 5. Ep.28
August 16, 2026 - - Podcast -
Melbourne biotech pursues an oral path to changing Type 1 diabetes
August 14, 2026 - - Australian Biotech -
A plain language version of these dreadful and useless documents
August 14, 2026 - - Latest News -
An institution dominated by very clever people, but where is the wisdom?
August 14, 2026 - - Latest News -
CUREator+ backs six Australian startups with $13.5 million to advance new health technologies
August 13, 2026 - - Australian Biotech

